SpaceX-Cursor Deal, SaaS Debt Bomb, New Apple CEO, SPLC Indictment, Colon Cancer Spike

The All-In hosts cover a range of tech and business updates, from an AI coding deal blending SpaceX and xAI strengths to SaaS struggles amid AI disruption, Apple's leadership shift, an indictment against the Southern Poverty Law Center, and research linking a pesticide to rising colon cancer in young people.

SpaceX Partners with Cursor on AI Coding Model

SpaceX announced a collaboration with Cursor, the AI coding startup, to build what they call the world's best coding and knowledge work AI. The structure: SpaceX will buy Cursor by end-2026 for $60 billion or pay a $10 billion collaboration fee, treated as a breakup fee by Bloomberg. Cursor's run rate hit $2 billion by late February, projecting $6 billion by end-2026; SpaceX expects $22-24 billion revenue then, making this accretive ahead of a potential IPO at $2 trillion valuation (80x revenue, Cursor at 30x). Cursor's Composer 2 model ranks between GPT-4.5 and Opus 4.6, built initially on Anthropic but now proprietary. xAI brings 550,000 GPUs (scaling to 1 million) in Colossus, solving Cursor's compute constraints. Hosts predict this combo vaults xAI, SpaceX, and Cursor to the top of coding leaderboards in 12 months, with Cursor's IDE, enterprise clients, and training data complementing xAI's foundation models and compute. The deal avoids S-1 refiling disruptions; Polymarket odds: 74% for acquisition, 80% for SpaceX IPO